Search

everythinglearnresearchcommunity

for

Search:↓

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Prevent persistent hair loss after chemotherapy with scalp cooling and early minoxidil use.

Suppressing ODC activity reduces tumor growth in hair follicles.

Men with early-onset hair loss are less responsive to bromocriptine's heart and metabolism benefits.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

Dutasteride may help treat prostate cancer by causing cancer cells to shrink and die.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

Osaterone acetate reduces prostate size and enzyme levels in dogs with benign prostatic hyperplasia.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

Photodynamic therapy improved skin issues from sorafenib when other treatments failed.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

A man's rash caused by Finasteride improved after stopping the drug and starting new treatments.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Using finasteride and doxazosina together works better for treating benign prostatic hyperplasia than using just one.

Adults with classic congenital adrenal hyperplasia value medication that prevents weight gain from glucocorticoids the most.

Exemestane may protect bones by stimulating osteoblast growth through androgen-related pathways.

Estrogen treatments can cause unwanted effects in men and should be used cautiously.

Targeting ornithine decarboxylase can help prevent skin cancer.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

5-Alpha-Reductase Inhibitors can cause negative side effects.

Finasteride, selenium, and vitamin E may help prevent prostate cancer.

The treatment slightly increased hair growth and was safe for most women.